Rankin G O, Yang D J, Cressey-Veneziano K, Wang R T, Brown P I
Toxicology. 1985 Jan;34(1):1-11. doi: 10.1016/0300-483x(85)90074-5.
Azaconazole is an experimental agricultural fungicide which has shown promise for use in controlling powdery mildew on crops and bean rust. This study examined the nephrotoxic potential of a single intraperitoneal azaconazole injection (0.4 or 0.6 mmol/kg) or daily azaconazole administration (0.1 or 0.3 mmol/kg/day) for 7 days in male Fischer 344 rats. The in vitro effects of azaconazole on the accumulation of organic ions by renal cortical slices also were examined. Acute azaconazole administration (0.4 or 0.6 mmol/kg, i.p.) produced a marked decrease in urine volume at 6 h. By 48 h urine volume was still decreased in the 0.6-mmol/kg group but not the 0.4-mmol/kg group. Proteinuria (++) and slight hematuria were seen in the 0.6-mmol/kg group on both treatment days. Accumulation of p-aminohippurate (PAH) by renal cortical slices was stimulated in both azaconazole-treated groups while tetraethylammonium (TEA) accumulation was not altered. No changes in blood urea nitrogen concentration, kidney weight or renal morphology were produced at 48 h postinjection by either azaconazole dose. Daily administration of azaconazole (0.1 or 0.3 mmol/kg/day) did not significantly alter any of the renal parameters studied. Incubation of renal cortical slices with increasing concentrations of azaconazole from 10(-5) M to 10(-3) M caused a continued reduction in TEA accumulation. PAH accumulation was decreased significantly following incubation with azaconazole 10(-5) or 10(-3) M. These results indicate that azaconazole is capable of producing acute, reversible renal effects at doses equal to or less than 0.6 mmol/kg and altering organic ion transport both in vivo and in vitro. The lack of marked renal effects following exposure to azaconazole is favorable for the development of this compound as an agricultural fungicide.
阿扎康唑是一种实验性农用杀菌剂,已显示出在控制作物白粉病和豆类锈病方面的应用前景。本研究检测了在雄性Fischer 344大鼠中单次腹腔注射阿扎康唑(0.4或0.6 mmol/kg)或每日给予阿扎康唑(0.1或0.3 mmol/kg/天),持续7天的肾毒性潜力。还检测了阿扎康唑对肾皮质切片有机离子蓄积的体外影响。急性给予阿扎康唑(0.4或0.6 mmol/kg,腹腔注射)在6小时时尿量显著减少。到48小时时,0.6 mmol/kg组尿量仍减少,但0.4 mmol/kg组未减少。在两个治疗日,0.6 mmol/kg组均出现蛋白尿(++)和轻微血尿。两个阿扎康唑治疗组肾皮质切片对对氨基马尿酸(PAH)的蓄积均受到刺激,而四乙铵(TEA)蓄积未改变。注射后48小时,两种阿扎康唑剂量均未引起血尿素氮浓度、肾脏重量或肾脏形态的变化。每日给予阿扎康唑(0.1或0.3 mmol/kg/天)对所研究的任何肾脏参数均无显著影响。用浓度从10(-5) M增加到10(-3) M的阿扎康唑孵育肾皮质切片导致TEA蓄积持续减少。与10(-5) 或10(-3) M阿扎康唑孵育后,PAH蓄积显著减少。这些结果表明,阿扎康唑在等于或低于0.6 mmol/kg的剂量下能够产生急性、可逆的肾脏效应,并在体内和体外改变有机离子转运。暴露于阿扎康唑后缺乏明显的肾脏效应有利于该化合物作为农用杀菌剂的开发。